containing sodium fluoride (NaF) compared to a CHX − MW alone on the parameters of plaque, gingivitis and discoloration?
| INTRODUCTION
Most patients are unable to achieve sufficient plaque removal by mechanical oral hygiene practices, so the relevance of the chemotherapeutic agents has increased with this perception. 1 Fluoride is the most popular chemotherapeutic agent, and it is widely used in many oral care products, such as toothpastes, mouthwashes and gels. 2, 4 Mouthwashes (MWs) are an ideal vehicle to incorporate in chemotherapeutic agents and are appreciated by the public because of their ease of use. With respect to antiplaque and antigingivitis effects, current evidence suggests that MWs containing chlorhexidine (CHX) are the first choice. 5 CHX was developed in England during the 1940s. It was marketed as an antiseptic and widely used in medicine and surgery. Plaque inhibition was first investigated in Switzerland by Renggli 6 and Schroeder. 7 A definitive study demonstrating inhibition of dental plaque was conducted by Löe et al. 8 It is certainly the most thoroughly studied chemotherapeutic agent. A comprehensive systematic review summarizing the results of 30 publications concluded that a CHX − MW provides significant reductions in plaque and gingivitis scores. 9 Chlorhexidine has a property so-called substantivity, which implies that antibacterial effects are sustained for longer periods. As it is cationic, it can be adsorbed to oral tissues such as hydroxyapatite, tooth surfaces, oral mucosa and salivary mucins for extended periods. It is subsequently released when the CHX concentration in the oral cavity is reduced. This exerts a plaque-inhibitory effect within the oral cavity that may last up to 12 hours. 5 In this respect, a combination of CHX and NaF has demonstrated favourable properties. In the presence of fluoride, the affinity of CHX for hydroxyapatite increases. 10 This may reduce the effective concentration of CHX needed, as well as the frequency of use. The addition of fluoride to a CHX mouthwash also has been shown to inhibit caries development. 11 In such a case, the fluoride provides an adjunctive beneficial remineralization effect to the CHX mouthwash.
Chemically, CHX is made up of two 4-chlorophenyl rings and 2
biguanide groups linked by a central hexamethylene chain, which confers a strong basicity and a bicationic charge. Its bicationic nature makes it highly interactive with any anionic element. 3 CHX has the ability to form low-solubility salts with anions such as sulphate, phosphate and chloride thus making its formulation into oral hygiene products, without losing its antiseptic properties through interactions with other ingredients, much more difficult. 13 A fluoride, which is used commonly in dentifrices, monofluorophosphate (MFP), was studied for its possible compatibility in formulations with CHX. 12 When clinically relevant concentrations were used, a large portion of the free CHX was eliminated, leading the authors to conclude that MFP and CHX are not compatible. 12 But there is also clinical evidence that indicates that sodium fluoride (NaF) and CHX in the same vehicle do not decrease the presence of free ionized fluoride nor reduce the availability of CHX below therapeutic levels. 14, 15 Because of these contradictory results, it remains unclear whether CHX and fluoride can be used together in a single MW regarding its effect on the reduction in plaque and gingivitis. A comprehensive search and systematic analysis of the current available literature on the parameters of plaque and gingivitis will show us if CHX keeps its properties when combined with NaF.
The outcome of this may guide dental care professionals in providing evidence-based oral hygiene advice to their patients with plaque and gingivitis. Therefore, the purpose of this study was to systematically and critically appraise the available scientific evidence concerning the efficacy of a CHX + NaF − MW compared to a CHX − MW alone with respect to plaque, clinical parameters of gingivitis and tooth discoloration.
| MATERIAL AND METHODS
This systematic review was prepared and described in accordance with the Cochrane handbook for systematic reviews of interventions 16 and the guidelines of Transparent Reporting of Systematic
Reviews and Meta-analyses (PRISMA). 17, 18 The protocol that details the review method was developed a priori following an initial discussion among the members of the research team.
| Focused question
What is the efficacy of a chlorhexidine (CHX) mouthwash (MW) with sodium fluoride (NaF) as an additional ingredient compared to a CHX − MW without NaF on the parameters of plaque, gingivitis and tooth discoloration in gingivitis patients?
| Search strategy
A structured search strategy was designed to retrieve all relevant 
| Screening and selection
Titles and abstracts from the studies obtained by the searches were independently screened by 2 reviewers (TAE, DES) to select studies that potentially met the inclusion criteria. Only English papers were accepted. Based on the title and abstract, the full-text versions of potentially relevant papers were obtained. These were categorized as definitely eligible, definitely not eligible or questionable.
Disagreements concerning eligibility were resolved by consensus or, if disagreement persisted, by arbitration through a third reviewer (GAW). The papers that fulfilled all of the inclusion criteria were processed for data extraction.
The inclusion criteria were as follows:
• Published in the English language 
| Assessment of heterogeneity
The factors used to evaluate the heterogeneity of the outcomes of the different studies were as follows:
• Study design, groups and evaluation period
• Subjects' characteristics
• Side effects and industry funding
| Quality assessment
Two reviewers (TAE, DES) independently scored the individual methodological qualities of the included studies using the checklist as presented in Appendix S1 according to the method described in detail by Keukenmeester et al. 19 In short, a study was classified as having a "low risk of bias" when random allocation, defined inclusion/exclusion criteria, blinding to patient and examiner, balanced experimental groups, identical treatment between groups (except for the intervention) and reporting of follow-up were present. Studies that fulfilled 6 of these 7 criteria were considered to have a potential moderate risk of bias. If 2 or more of these 7 criteria were absent, the study was considered to have a high risk of bias. 
| Data extraction
The characteristics of the population, intervention, comparison and outcomes were extracted independently from all studies by 2 reviewers (TAE, DES) using a specially designed data extraction form. Disagreement between the reviewers was resolved through discussion and consensus. If a disagreement persisted, the judgement of a third reviewer (GAW) was decisive. Some of the studies provided standard errors (SE) of the mean. If needed and where possible, the authors calculated the standard deviation based on the sample size (SE = SD/√N). For those papers that provided insufficient data to be included in the analysis, the first and/or corresponding authors were contacted to request additional data.
| Data analysis
The studies were categorized as a monotherapy (non-brushing studies) or as an adjunct to self-performed daily oral hygiene (brushing studies). In the non-brushing studies using a de novo plaque accumulation model, only plaque was the parameter of interest.
While for the non-brushing studies using an experimental gingivitis model and for the brushing studies, plaque, bleeding, gingivitis and discoloration were taken into account. As a summary, a de- other group, the number of subjects (n) in the group was divided by the number of comparisons. A meta-analysis was only performed if more than 1 study could be included irrespective of the number of comparisons. The difference of means (diffM) between test and control was calculated using a "random or fixed effects" model where appropriate. A fixed-effect analysis was implemented if there were fewer than 4 studies because the estimate of between-study variance is poor for analyses with low numbers of studies. 16 The formal testing for publication bias was used as proposed by Egger et al. 21 
| Grading the "body of evidence"
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to rank the evidence. 22 Two reviewers (DES, GAW) rated the quality of the evidence and the strength and direction of the recommendations 23 according to the following aspects:
risk of bias, consistency of results, directness of evidence, precision and publication bias and magnitude of the effect. Any disagreement between the 2 reviewers was resolved after additional discussion.
| RESULTS

| Search and selection results
Searching Manual searching of the reference lists did not reveal other publications.
Altogether, the final 9 eligible publications presenting 10 clinical trials provided 13 comparisons, which were included in this systematic review.
| Assessment of heterogeneity
Some heterogeneity was observed in the 10 clinical trials with respect to study design, participants, and MW brands used as the brushing/ rinsing regimen among the studies. Table 1 presents information regarding the study characteristics. Figure 1 ).
| Study design, groups and evaluation period
| Subject characteristics
All studies included participants in good general health. were (partly) sponsored by the industry (GABA Dentaid and Actavis, respectively). Two of the 5 authors in study III 3 had affiliations with the industry, and they acknowledged the grant that was provided by the industry (Lácer S.A.).
| Side effects and industry funding
| Methodological quality assessment
The potential risk of bias was estimated based on the methodological quality aspects of the included studies as presented in the Appendix The combination of CHX and NaF in a MW showed the same clinical effect as the CHX solution CHX, chlorhexidine; NaF, sodium fluoride; CPC, CetylPyridinium chloride; RCT, randomized controlled clinical trials; CCT, controlled clinical trials, ? = unknown/not provided.
T A B L E 1 (Continued) S1. Based on a summary of the proposed criteria, the potential risk of bias was estimated to be moderate for the studies VI 35 and VIII 37 and low for the other studies.
| Study outcomes results
The Appendix S2-S5 presents the data extraction results of the selected studies for the various clinical indices. When available, the baseline, end scores and the changes between baseline and end scores are presented. Table 2 summarizes the descriptive analysis for the statistical differences between CHX + NaF and CHX alone presented for the nonbrushing and brushing studies. All 9 comparisons evaluating bleeding F I G U R E 1 Search and selection results.
| Between groups
PS=Plaque Score, GI=Gingival Index, BS=Bleeding Score, DS=Discoloration Score, *2 indices were used for the same parameter
PubMed-MEDLINE 342
Cochrane-CENTRAL 137
Excluded by title and abstract 395
Excluded after full reading 8
Non-brushing 8 EMBASE 158
Final Selection Table 3a -c summarize the detailed data outcomes of the performed meta-analysis.
Appendix S6-S13 presents the corresponding forest plots. No statistical difference was detected at baseline nor at the end. Testing for publication bias could not be performed because fewer than 10 studies were included in the meta-analysis, which would result in insufficient statistical power.
16,21 Table 4 presents a summary of the various factors used to rate the quality of evidence and to appraise the strength and direction of recommendations according to GRADE. 22 There is no difference in plaque control between CHX + NaF − MW and CHX − MW. However, due to inconsistency and a low precision, the strength of the recommendation was an estimate to be "very weak" resulting in a low certainty that CHX -NaF − MW favours CHX − MW for plaque control. No difference was determined between the gingival inflammation parameters and tooth surface discoloration. Given the strength of the recommendation, there is a "moderate" certainty that the addition of NaF does not negatively influence the effect of CHX on gingival inflammation.
| Evidence profile
With respect to tooth surface discoloration, no difference between the CHX − MW was noted. The strength of the observation that side effects with either product were comparable was estimated to be "weak."
| DISCUSSION
This review selected studies that provide information concerning the question if CHX is still active when combined with NaF in an MW.
So the included studies evaluated the efficacy of a CHX − MW with NaF compared to a CHX − MW on the plaque, gingivitis and discoloration scores. No difference between the 2 products was observed.
The potential adjunctive effect of NaF on remineralization was not investigated in this review. In total, 9 publications with 10 clinical trials were included with 13 comparisons. The results indicate that CHX solutions combined with fluoride and those without demonstrate similar effects in the plaque and gingivitis scores (Table 2) confirmed by a meta-analysis (Table 3a -c). Gingival inflammation measured based on bleeding and discoloration scores support these findings in the descriptive analysis.
| Chemical classification
Chemically, CHX is comprised of 2 4-chlorophenyl rings and 2 biguanide groups linked by a central hexamethylene chain, which confers a strong basicity and a bicationic charge. Its bicationic nature makes it highly interactive with any anionic element. 3 It is therefore not easily formulated into an MW product because other ingredients in the MW formulation may interact with CHX and inhibit its activity. 12 It is known that sulphate, phosphate and chloride react with the CHX. For instance, the resultant product of the reaction of CHX with chloride is chlorhexidine dichloride, +, significant difference in favour of the CHX + NaF group; -, significant difference in favour of the CHX group;0, no significant difference; □, no data available; NA, not applicable; PS, Plaque Score; GI, Gingival Index; BS, Bleeding Score; DS, Discoloration Score.
a compound that is a low-solubility salt. 13 Thus, due to potential interactions, the antibacterial activity of a CHX solution cannot be taken for granted and can even differ between different MW brands. 32 For decades, a view has circulated in the scientific (dental) society that CHX and fluoride would be chemically incompatible when used together. 33 Fluoride is a highly electronegative halogen, most commonly used in the prevention of dental caries to strengthen tooth structure. There is evidence that, when used together for caries prevention, CHX and fluoride provide additive benefits and together may prove valuable in the prevention of oral diseases. 11 Chlorhexidine and fluoride combined will result in chlorhexidine difluoride. Research has shown that chlorhexidine difluoride ionizes to the same extent as sodium fluoride in aqueous solutions. 53 Some research indicates that reduced availability of CHX is unlikely to occur due to the incorporation of NaF in a formulation. Unlike monofluorophosphate (MFP), 12 NaF appears compatible with CHX both in the rinse 26, 27 and toothpaste formulations 47 when compared to an inactive ingredient placebo. It is more likely, however, that other ingredient in the CHX + NaF − MW are complexing some of the CHX and reducing the availability of this antiseptic. 31 A likely candidate would be sodium lauryl sulphate (SLS), which is the most commonly used anionic detergent in oral hygiene products. SLS assists in the solubilization of flavouring agents, but "in vitro" research has demonstrated that SLS and CHX may act as antagonists. 48 Recently, the potential effect of SLS from dentifrice slurry on CHX efficacy was evaluated. Based on the collective evidence, it was concluded that under normal brushing circumstances, an SLS dentifrice could be used without any interference with CHX activity regarding its inhibiting effect on the dental plaque. 
| Parameters of interest
Data with respect to plaque index scores were inconclusive because in 3 of the 5 comparisons evaluating plaque measurements by the de 35 was in favour of the CHX + NaF (Table 2) .
No difference in tooth discoloration was observed between CHX + NaF − MW and CHX − MW (Table 2 ). Claydon et al 42 has suggested that CHX discoloration can serve as a surrogate but less substantive parameter of efficacy. They hypothesized that if discoloration was reduced, CHX could be inhibited. The absence of a significant difference in all included studies with respect to tooth discoloration would than suggests that the addition of NaF does not negatively affect CHX activity.
| Research design
The first category of clinical trials to test a chemotherapeutic agent should be designed to evaluate the antiplaque and antigingivitis effects of the compound incorporated in the MW. In this case, the "experimental gingivitis" design is highly suitable. 56 In the litera- an effect on plaque scores in favour of the CHX + NaF − MW.
| Heterogeneity
The included studies were heterogeneous in terms of study design and duration, CHX concentration, rinsing volume, duration of rinsing, addition of ethanol or CPC and manufacturers. CHX concentrations varied from 0.05% to 0.2%. A recent Cochrane SR stated that here is high-quality evidence of a large reduction in dental plaque with CHX − MW used as an adjunct to mechanical oral hygiene procedures for 4 to 6 weeks and 6 months. And also that there is no evidence that one concentration of chlorhexidine rinse is more effective than another. 57 In a previous SR, the effectiveness of 0.12% vs 0.2%
T A B L E 4 Estimated evidence profile (GRADE, 2015), appraisal of the strength of the recommendation and the direction regarding the efficacy of CHX + NaF − MW as compared to CHX − MW alone with respect to the various parameters of interest The results of this analysis demonstrated that none of these variables contributed to the observed effect of CHX. This is supported by a recent RCT demonstrating that the twice-daily use of 0.2% CHX with or without alcohol in combination with brushing with standard fluoride toothpaste comparably reduced plaque and gingival inflammation after 6 weeks of treatment following a complete prophylaxis. 
| Best of both worlds?
The fluoride-chlorhexidine association was proposed almost 4 decades ago 11 for a synergistic effect of the 2 drugs to control caries and gingivitis. A combination of an anticaries and antiplaque agent may be useful and provide added benefits and may prove valuable in the prevention of oral diseases. Also with respect to dentin hypersensitivity, 50 it was noted that CHX + NaF was more effective than NaF alone in reducing dentin hypersensitivity. As an explanation, the authors suggested that this might be due to the combined effect of plaque reduction and obliteration of dentin tubules. With the removal of plaque, the dentinal tubule apertures are optimally exposed to mineralization effects of saliva and fluoride. The present review does not address the effect that CHX may have on the concentration of NaF in the MW. It has, however, been shown in the past that, when combined together in the same vehicle, NaF and CHX do not decrease the presence of free ionized fluoride. 15 The amount of fluoride retained in the mouth as well as the subsequent salivary fluoride concentrations were essentially the same for CHX + NaF and NaF rinses. 51 Based on research with CHX and NaF varnishes, it was proposed that CHX and fluoride might even act synergistically. 
| Limitations
• The English language restriction could have introduced a language bias. However, over the years, the extent and effects of such a possible bias may have diminished because of the shift towards publication in English. 16 • The subjects participating in the included studies differed and were in none of the studies representative of regular dental practice patients. Study V 34 included medical students, whereas the par- ) included 13-to 25-yearold participants from a school or a specialized orthodontic practice and, in addition, had a (partial) mixed dentition. These groups most likely are not the regular user population.
• Differences in the composition of the study products exist because in some studies the MW also contained ethanol or CPC as an ingredient. This could have had an impact on study outcomes that we
were not able to analyse.
| Recommendation for further research
The present review has shown that CHX − MW can be combined with NaF without losing the CHX effect on the plaque and gingivitis. It is, however, unclear if conversely CHX affects the properties of fluoride.
Therefore, if an adjunctive remineralization potential is indicated, it still is "uncertain" whether a CHX + NaF − MW is an appropriate product. As CHX and fluoride may chemically interact, this aspect deserves further research before a recommendation can be given in favour of the CHX -NaF − MW.
| Conclusion
From this study, it can be concluded that NaF and CHX may be present in the same MW without reducing CHX efficacy with respect to plaque and gingivitis scores. Moreover, no difference in the development of tooth discoloration was observed.
| CLINICAL RELEVANCE
| Scientific rationale for the study
Chlorhexidine (CHX) is a well-known antiseptic and sodium fluoride (NaF) is often used to prevent tooth decay. They have opposite charges and, based on their chemistry, may interact when used in the same mouthwash (MW).
| Principle findings
No significant difference in plaque, bleeding, gingival scores and discoloration was observed.
| Practical implications
When CHX and NaF are combined in an MW, the plaque and gingivitis inhibiting effect is comparable to a regular CHX − MW. Tentatively, the addition of NaF to a CHX − MW provides apart from an antimicrobial effect the potential to promote remineralization. The latter still deserves further investigation.
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